Creative Medical Technology Holdings

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.

Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study. The initial study showed significant efficacy of the StemSpine procedure for treating chronic lower back.

Why Creative Medical Technology Shares Are Soaring

Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study.

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Creative Realities Inc

Hycroft Mining Holding Corporation

Here's what you need to know about trading penny stocks on March 23rd The post Trading Penny Stocks? Top Stock Market News For March 23rd, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trading Penny Stocks? Top Stock Market News For March 23rd, 2022

--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients Using StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX, March 23, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive two-year follow-up data for the Company's StemSpine® pilot study, showing significant efficacy of the StemSpine® procedure for treating chronic lower back pain without any serious adverse effects reported. StemSpine® is a patented procedure that utilizes a patient's own bone marrow aspirate for the treatment of chronic lower back pain.

Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study

PHOENIX, March 8, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that Company executives will be participating in the 34th Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. Management will be available for one-on-one meetings throughout the conference.

Creative Medical Technology to Participate in the 34th Annual Roth Conference

PHOENIX, Ariz. , March 2, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced the appointment of Sahil Nock as the Company's Chief Commercial Officer, effective February 28, 2022.

Creative Medical Technology Appoints Sahil Nock as Chief Commercial Officer

Agriforce Growing Systems Ltd

Datasea Inc

Hookipa Pharma Inc

loanDepot

Maris-Tech

Revelation Biosciences

vTv Therapeutics

Low float penny stocks to add to your watch list right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now

Flotek Industries

Here's what you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for February 18th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trading Penny Stocks? Top Stock Market News for February 18th, 2022

Low float penny stocks to watch right now. The post 4 Low Float Penny Stocks To Watch After ISPO Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Low Float Penny Stocks To Watch After ISPO Stock Explodes

FuelCell Energy

SmileDirectClub

Stran & Co

Short squeeze penny stocks to watch The post 4 Top Penny Stocks To Watch For A Short Squeeze appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Penny Stocks To Watch For A Short Squeeze

G Medical Innovations Holdings Ltd

Lixte Biotech

Leap Therapeutics

Nuverra Environmental Solutions

SeaChange International

Tellurian

Short squeeze penny stocks to watch right now. The post 7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now

Will these penny stocks see a short squeeze this week? The post Short Squeeze Penny Stocks To Buy Now?

Short Squeeze Penny Stocks To Buy Now? 4 To Watch Under $5

Diversified Healthcare Trust

IMAC Holdings Inc

Quoin Pharmaceuticals Ltd

What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now?

Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today

Armstrong Flooring

Applied UV

BlueCity Holdings Limited

Genprex

PolarityTE Inc

Eco Wave Power Global AB

We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE appeared first on InvestorPlace.

8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE

Creative Medical Technology (CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company. The post CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology appeared first on InvestorPlace.

CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology

Immix Biopharma

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Today?

Best Penny Stocks to Buy Today? 3 For Your Watchlist in January

The stock price of Creative Medical Technology Holdings Inc (NASDAQ: CELZ) increased by over 50% pre-market today. This is why it happened.

Creative Medical Technology Stock (CELZ): Why The Price Surged Today

Pop Culture Group Co Ltd

Twin Vee PowerCats Co

Low float penny stocks to add to your watch list this week The post Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250%

PHOENIX, Dec. 3, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (the "Company") (NASDAQ: CELZ), a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced the pricing of the underwritten public offering of 3,875,000 shares of common stock and accompanying warrants to purchase up to 3,875,000 shares of common stock at a combined public offering price of $4.13.  The warrants have a per share exercise price of $4.13, are exercisable immediately, and expire five years from the date of issuance.

Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market

PHOENIX, Nov. 9, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings, Inc. (the "Company"), a commercial stage biotechnology company focused on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications, today announced its intention to effect a 1-for-500 reverse split of its common stock in preparation for a planned listing of the Company's securities on The Nasdaq Capital Market ("Nasdaq"). The reverse stock split will become effective at the open of business on Wednesday, November 10, 2021, and the Company's common stock will begin trading on the OTC Markets system on a split-adjusted basis under the temporary ticker symbol "CELZD" at that time.

Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market

News for Creative Medical Technology Holdings Stock (CELZ)